Follow The Filings

RANI Rani Therapeutics Holdings Inc.

Health Care, filed as RANI THERAPEUTICS HLDGS INC (COM CL A), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

  • 1 Owner
  • $16K

Who owns RANI

Sorted by value, long equity only, as of 2026 Q3.

History
Farallon Capital Management <0.01% Hold 20,700 $16K History

Insider trades

Open-market buys and sales by RANI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All RANI insider trades
  • $50K bought by 2 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Mir A. Imran Director
    Buy
    $25K 36,000 shares at $0.6900 +1.7% to stake
    Traded Jul 21 Filed Jul 23
  2. Talat Imran CEO
    Buy
    $25K 35,000 shares at $0.7200 +8.1% to stake
    Traded Jul 17 Filed Jul 21
  3. Mir A. Imran Director
    Buy
    $1.3M 2,083,334 shares at $0.6100 New stake
    Traded Oct 23, 2025 Filed Oct 27, 2025
  4. South Cone Investments Limited Partnership 10% owner
    Sale
    $15.7M 5,923,000 shares at $2.65 71% of stake
    Traded Oct 20–21 Filed Oct 22, 2025

Also filed in the last 12 months, not counted as buying or selling: 7 share withholdings for taxes and 1 sale to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 23 shown.

Filed Form Detail Links
8-K 3.01
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
8-K 5.02
SCHEDULE 13G/A —
8-K 5.02,9.01
8-K 5.07
SCHEDULE 13D/A —
424B5
8-K 8.01,9.01
SCHEDULE 13G/A —
8-K 2.02,3.01,5.02,9.01
10-Q
SCHEDULE 13G —
DEF 14A
DEFA14A DEFA 14A
SCHEDULE 13G/A —
8-K 2.02,9.01
10-K

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue — $1.03M $1.63M
Net income -$33.97M -$30.02M -$29.67M
Net margin * — -2920.0% -1817.1%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $50.85M $29.74M $53.32M
Total non-current assets * $7.07M $6.89M $5.3M
Total assets $57.92M $36.63M $58.62M
Total current liabilities $7.99M $19.89M $12.67M
Total non-current liabilities * $24.48M $13.25M $4.44M
Total equity $12.87M $1.99M $33.01M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$51.24M -$35.5M -$18.71M
Cash from investing $29.86M $19.81M -$7.03M
Cash from financing $0.233M $13.58M $40.3M
Net change in cash -$21.14M -$2.1M $14.56M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf